Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Animal Pharm Podcast #17: Improved investment environment still needs specialized funds

Animal Pharm's most recent webinar highlighted the ongoing paucity of specialized investors in the animal health sector.

The podcast below is a recording of the webinar, which focused on the trends shaping the current landscape of animal health investment. Animal Pharm editor Joseph Harvey spoke to Charles Hoare (head of European healthcare investment banking at Stifel), Phil Austin (founding partner at Anterra Capital) and Jochem Bossenbroek (chief executive of Dutch start-up BunyaVax) about a variety of subjects during the webinar.

While recent years have witnessed an improved environment for funding in the animal health sector, this has largely come from investors with portfolios across multiple sectors. 

The presentation is also available here.

The topics covered during the webinar included:

  • The investment community's stance on the animal health sector;

  • The portions of the industry ripe for investment;

  • The main obstacles to funding;

  • Advice for start-ups seeking investment;

  • The level of support offered to start-ups by the larger animal health companies;

  • The viability of funding for the animal microbiome space; and

  • Mega-mergers and IPOs.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts